These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 31101215)
1. Non-Hodgkin Lymphoma in a Kidney Transplant Patient: A Case Report. Illésy L; Szabó RP; Kovács DÁ; Fedor R; Nemes B Transplant Proc; 2019 May; 51(4):1286-1288. PubMed ID: 31101215 [TBL] [Abstract][Full Text] [Related]
2. Rituximab therapy and reduction of immunosuppression to rescue graft function after renal posttransplantation lymphoproliferative disorder found by macrohematuria in a pancreas and kidney transplant recipient: a case report. Miyagi S; Sekiguchi S; Kawagishi N; Akamatsu Y; Satoh K; Takeda I; Fukushima D; Kobayashi Y; Tokodai K; Fujimori K; Satomi S Transplant Proc; 2011 Nov; 43(9):3299-301. PubMed ID: 22099782 [TBL] [Abstract][Full Text] [Related]
3. Administration of Antithymocyte Globulin (Rabbit) to Treat a Severe, Mixed Rejection Episode in a Pregnant Renal Transplant Recipient. Kutzler HL; Ye X; Rochon C; Martin ST Pharmacotherapy; 2016 Apr; 36(4):e18-22. PubMed ID: 26892892 [TBL] [Abstract][Full Text] [Related]
4. Rituximab induction therapy in highly sensitized kidney transplant recipients. Yin H; Wan H; Hu XP; Li XB; Wang W; Liu H; Ren L; Zhang XD Chin Med J (Engl); 2011 Jul; 124(13):1928-32. PubMed ID: 22088448 [TBL] [Abstract][Full Text] [Related]
5. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes. Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960 [TBL] [Abstract][Full Text] [Related]
6. [Lymphoproliferative disease following kidney transplantation]. Merkle M; Rupprecht HD Dtsch Med Wochenschr; 2005 Jul; 130(28-29):1691-4. PubMed ID: 16003604 [TBL] [Abstract][Full Text] [Related]
7. Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma. Carella AM; Cavaliere M; Lerma E; Ferrara R; Tedeschi L; Romanelli A; Vinci M; Pinotti G; Lambelet P; Loni C; Verdiani S; De Stefano F; Valbonesi M; Corsetti MT J Clin Oncol; 2000 Dec; 18(23):3918-24. PubMed ID: 11099321 [TBL] [Abstract][Full Text] [Related]
8. Double-hit monomorphic B-cell lymphoma after liver transplantation. Tahir Z; Peters J; Leahy K; Batalini F BMJ Case Rep; 2020 Jan; 13(1):. PubMed ID: 31900295 [TBL] [Abstract][Full Text] [Related]
9. Clinical factors associated with graft fibrosis in kidney-transplant recipients on steroid-avoidance immunosuppression. Heilman RL; Chakkera HA; Reddy KS; Colby TV; Moss AA; Williams JW; Mazur MJ; Petrides S; Mulligan DC Clin Transplant; 2008; 22(3):309-15. PubMed ID: 18482051 [TBL] [Abstract][Full Text] [Related]
10. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [TBL] [Abstract][Full Text] [Related]
11. Outcome of Patients With Non-Hodgkin Lymphomas With Concurrent MYC and BCL2 Rearrangements Treated With CODOX-M/IVAC With Rituximab Followed by Hematopoietic Stem Cell Transplantation. Sun H; Savage KJ; Karsan A; Slack GW; Gascoyne RD; Toze CL; Sehn LH; Abou Mourad Y; Barnett MJ; Broady RC; Connors JM; Forrest DL; Gerrie AS; Hogge DE; Narayanan S; Nevill TJ; Nantel SH; Power MM; Sutherland HJ; Villa D; Shepherd JD; Song KW Clin Lymphoma Myeloma Leuk; 2015 Jun; 15(6):341-8. PubMed ID: 25656914 [TBL] [Abstract][Full Text] [Related]
12. [Therapeutic management of central nervous system lymphomas in a single hematological institute]. Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012 [TBL] [Abstract][Full Text] [Related]
13. Posttransplant Lymphoproliferative Disorder in Kidney and Liver Transplant Recipients: A Single-Center Experience. Wójciak M; Gozdowska J; Dęborska-Materkowska D; Perkowska-Ptasińska A; Kosieradzki M; Nazarewski S; Durlik M Transplant Proc; 2018 Sep; 50(7):2154-2158. PubMed ID: 30177129 [TBL] [Abstract][Full Text] [Related]
14. Superior Patient and Graft Survival in Adult Liver Transplant with Rabbit Antithymocyte Globulin Induction: Experience with 595 Patients. Montenovo MI; Jalikis FG; Li M; Yeh M; Dick A; Hansen R; Reyes JD Exp Clin Transplant; 2017 Aug; 15(4):425-431. PubMed ID: 27309029 [TBL] [Abstract][Full Text] [Related]
15. Early post-transplant lymphoproliferative disorder – Case of fatal lymphoma after kidney transplantation. Laušević M; Markovic-Lipkovski J; Terzić T; Jovanović N; Milinković M; Naumović R Srp Arh Celok Lek; 2016; 144(5-6):325-8. PubMed ID: 29648755 [TBL] [Abstract][Full Text] [Related]
16. Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol. Jaber JJ; Feustel PJ; Elbahloul O; Conti AD; Gallichio MH; Conti DJ Clin Transplant; 2007; 21(1):101-9. PubMed ID: 17302598 [TBL] [Abstract][Full Text] [Related]
17. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group. Gruessner RW Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719 [TBL] [Abstract][Full Text] [Related]
18. Successful treatment with foscarnet for ganciclovir-resistant cytomegalovirus infection in a kidney transplant recipient: A case report. Iwami D; Ogawa Y; Fujita H; Morita K; Sasaki H; Oishi Y; Higuchi H; Hatanaka K; Shinohara N Nephrology (Carlton); 2016 Jul; 21 Suppl 1():63-6. PubMed ID: 26970406 [TBL] [Abstract][Full Text] [Related]
19. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol]. Mihaljević B; Jancić-Nedeljkov R; Sretenović M; Milivojević G; Janković S; Petrović M Srp Arh Celok Lek; 1998; 126(9-10):345-8. PubMed ID: 9863405 [TBL] [Abstract][Full Text] [Related]
20. The transmission of donor-derived malignant melanoma to a renal allograft recipient. Milton CA; Barbara J; Cooper J; Rao M; Russell C; Russ G Clin Transplant; 2006; 20(5):547-50. PubMed ID: 16968479 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]